Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
abortion, spontaneous
acetylcholine receptor
acetylcholine receptor antibody
acetylcholinesterase
acetylcholinesterase deficiency
adverse drug reaction
airway obstruction
alpha-fetoprotein
anemia
anesthesia, general
anesthesia, local
antibiotics
antibiotics, neurologic complications with
antimetabolite
areflexia
arthrogryposis multiplex
asthma
autoimmune disease
azathioprine
blacks
botulism
breast feeding
bulbar palsy
bulbar palsy, acute
bulbar palsy, juvenile
bulbar palsy, progressive
carcinoma
cesarean section
children
collagen vascular disease
congenital malformation
congenital myasthenic syndromes
cough
delay in diagnosis
delivery, complicated
developmental milestones
developmental milestones, loss of
developmental retardation
diabetes mellitus
difficulty climbing stairs
diplopia
drug induced neurologic disorders
dysarthria
dysphagia
dysphonia
electromyogram
electromyogram, decremental response
ephedrine
epidemiology of neurology
facial weakness
facial weakness, bilateral
familial
fatigue
floppy infant
gammaglobulin therapy, intravenous
gene mutation
genetic neurologic disorders
genetic testing
heralding manifestation
hyperthyroidism
hyporeflexia
hypotonia
hypotonia, infants
immunologic disease
immunosuppressive agents
labor, complicated
magnesium sulfate
Mary Walker phenomenon
masked facies
mestinon
misdiagnosis
mortality
muscle weakness, proximal
myasthenia gravis
myasthenia gravis, classification
myasthenia gravis, congenital
myasthenia gravis, distal weakness
myasthenia gravis, etiology of
myasthenia gravis, familial incidence of
myasthenia gravis, infantile and juvenile
myasthenia gravis, limb-girdle
myasthenia gravis, misdiagnosis of
myasthenia gravis, neonatal
myasthenia gravis, neuromuscular junction in
myasthenia gravis, ocular
myasthenia gravis, passive transfer of
myasthenia gravis, presenting manifestations
myasthenia gravis, prognosis of
myasthenia gravis, receptor site in
myasthenia gravis, remission of
myasthenia gravis, seronegative
myasthenia gravis, thymectomy in
myasthenia gravis, treatment of
myasthenic crisis
myasthenic syndrome
mycophenolate
nasal speech
nerve conduction studies
neurologic disease, diagnoses of
neuromuscular disease, electrodiagnosis of
neuromuscular junction
newborn, evaluation of
next-generation sequencing
ophthalmoplegia
pancytopenia
plasmapheresis
postpartum
practice guidelines
pregnancy, neurologic complications in
prognosis
psychosis, acute
ptosis
ptosis, bilateral
remission
repetitive nerve stimulation
respiratory depression
respiratory failure
review article
rheumatoid arthritis
rheumatoid arthritis, neurologic complications of
risk factors
rituximab
running
safety
seizure
serologic testing
serologic testing, false negative
seronegative
steroid
steroid therapy, CNS treatment and complications with
stillbirth
stridor
systemic lupus erythematosus
systemic lupus erythematosus, neonatal
systemic lupus erythematosus, neurologic complications with
tensilon test, false negative
thymectomy
thymus and neuromuscular function
treatment of neurologic disorder
vocal cord paralysis
weakness
weakness, fatiguable
weakness, generalized
weaning from respirator, failure to
whites
workup
xerostomia
Showing articles 550 to 600 of 657 << Previous Next >>

Ideomotor Apraxia in Huntington's Disease
Arch Neurol 48:35-41, Shelton,P.A.&Knopman,D.S., 1991

Myoclonus in Adult Huntington's Disease
Ann Neurol 29:213-215, Vogel,C.M.,et al, 1991

Epileptic Seizures and Syndromes
Lancet 336:161-163, Gram,L., 1990

Genetic Testing for Huntington's Disease
BMJ 300:1089-1090, Harper,P.,et al, 1990

Abnormalities of Striatal Projection Neurons and n-Methyl-d-Aspartate Receptors in Presymptomatic Huntington's Disease
NEJM 322:1293-1298, Albin,R.L.,et al, 1990

Chronic Acetazolamide Monotherapy in the Treatment of Juvenile Myoclonic Epilepsy
Neurol 40:1677-1681, Resor,S.R.&Resor,L.D., 1990

Dopa Responsive Dystonia:A Treatable Condition Misdiagnosed as Cerebral Palsy
BMJ 298:1019-1020, Boyd,K.&Patterson,V., 1989

Clinical-Pathologic Correlation in Huntington's Disease:A Neuropsychological and Computed Tomography Study
Neurol 39:796-801, Bamford,K.A.,et al, 1989

Juvenile Myoclonic Epilepsy:An Autosomal Recessive Disease
Ann Neurol 25:440-443, Panayiotopoulos,C.P.&Obeid,T., 1989

Predictive Testing for Huntington's Disease with Linked DNA Markers
Lancet 2:463-466, Brock,D.J.H.,et al, 1989

Problems in Genetic Prediction for Huntington's Disease
Lancet 2:601-603, Morris,M.J.,et al, 1989

Uptake of Presymptomatic Predictive Testing for Huntington's Disease
Lancet 2:603-605, Craufurd,D.,et al, 1989

Predictive Testing for Huntington's Disease, Progress and Problems
BMJ 298:404-405, 1989, Harper,P.S.&Morris,M.J., 1989

Adoption and Genetic Prediction for Huntington's Disease
Lancet 2:1069-1070, Morris,M.,et al, 1988

Huntington's Disease Mortality in the United States
Neurol 38:769-772, Lanska,D.J.,et al, 1988

Presymptomatic Neuropsychological Impairment in Huntington's Disease
Arch Neurol 45:769-773, Jason,G.W.,et al, 1988

Autonomic Nervous Function in Huntington's Disease
Arch Neurol 45:309-312, DenHeijer,J.C.,et al, 1988

Predictive Testing for Huntington's Disease with Use of a Linked DNA Marker
NEJM 318:535-542, Meissen,G.J.,et al, 1988

Tetrabenazine Therapy of Dystonia, Chorea, Tics, & Other Dyskinesias
Neurol 38:391-394, Jankovic,J.&Orman,J., 1988

The Molecular Genetic Revolution, Its Impact on Clinical Neurology
Arch Neurol 45:1366-1376, Payne,C.S.&Roses,A.D., 1988

Huntington's Disease:Deterioration in Clinical State During Treatment with ACE Inhibitor
BMJ 294:1659-1660, Goldblatt,J.&Bryer,A., 1987

The Combined Use of Positron Emission Tomography & DNA Polymorphisms for Preclinical Detection of Huntington's Disease
Neurol 37:1441-1447, Hayden,M.R.,et al, 1987

First-Trimester Prenatal Diagnosis for Huntington's Disease with DNA Probes
et al Lancet 1:1284-1285, Hayden,M.R., 1987

Genetic Linkage in Neurologic Diseases
Editorial, NEJM 316:1018-10201987., Martin,J.B., 1987

Juvenile Parkinsonism:Clinical & Metabolic Characteristics
JNNP 50:345-348, Lima,B.,et al, 1987

Normal Caudate Glucose Metabolism in Persons at Risk for Huntington's Disease
Arch Neurol 44:254-257, Young,A.B.,et al, 1987

Reduced Cerebral Glucose Metabolism in Asymptomatic Subjects at Risk for Huntington's Disease
NEJM 316:357-362, Mazziotta,J.C.,et al, 1987

PET Scan Investigations of Huntington's Disease:Cerebral Metabolic Corr. of Neuro & Funct Decline
Ann Neurol 20:296-303, Young,A.B.,et al, 1986

Hereditary Dystonia-Parkinsonism Syndrome of Juvenile Onset
Neurol 36:1424-1428, Nygaard,T.C.&Duvoisin,R.C., 1986

The Role of Glutamate in Neurotransmission & in Neurologic Disease
Arch Neurol 43:1058-1063, Greenamyre,J.T., 1986

Neuropeptides in Neurological Disease
Ann Neurol 20:547-565, Beal,M.F.&Martin,J.B., 1986

Subcortical Dementia
BMJ 292:1035-1036, Foster,J.B., 1986

Positron Emission Tomography in the Early Diagnosis of Huntington's Disease
Neurol 36:888-894, Hayden,M.R.,et al, 1986

The Diagnosis of Huntington's Disease
Neurol 36:1279-1283, Folstein,S.E.,et al, 1986

Huntington's Disease, Pathogenesis & Management
NEJM 315:1267-1276, Martin,J.B.&Gusella,J.F., 1986

The Gait Abnormality of Huntington's Disease
Neurol 35:1450-1454, Koller,W.C.&Trimble,J., 1985

Presymptomatic Testing for Huntington's Disease
JAMA 253:3286-3291, Bird,S.J., 1985

Genetic Prediction & Family Structure in Huntington's Chorea
BMJ 290:1929-1931, Harper,P.S.,et al, 1985

Dysphagia in Huntington's Disease
Arch Neurol 42:57-60, Leopold,N.A.,et al, 1985

A DNA Polymorphism for Huntington's Disease Marks the Future
Arch Neurol 42:20-24, Wexler,N.S.,et al, 1985

Genetic Testing in Huntington's Disease
Ann Neurol 16:511-513, Koller,W.C.,et al, 1984

Increased Rate of Suicide Among Patients with Huntington's Disease
JNNP 47:1283-1287, Schoenfeld,M.,et al, 1984

Apraxia of Eyelid Opening in Progressive Supranuclear Palsy
Ann Neurol 15:115-116, Dehaene,I., 1984

Monomelic Amyotrophy
Arch Neurol 41:388-394, Gourie-Devi,M.,et al, 1984

Benign Focal Amyotrophy
Arch Neurol 41:678-679, Riggs,J.E.,et al, 1984

Clinicopathological Conference Metachromatic Leukodystrophy (juvenile type)
Case 7-1984, NEJM 310:445-4551984., , 1984

Computed Tomography in Late-Onset Metachromatic Leucodystrophy
Neuroradiology 26:39-44, Schipper,H.I.,et al, 1984

Evoked Potentials in Huntington's Disease
Arch Neurol 41:379-382, Ehle,A.L.,et al, 1984

Parental Transmission in Huntington's Disease
Lancet 1:1100-1102, Went,L.N.,et al, 1984

A Genetic Marker for Huntington's Chorea
BMJ 287:1567-1568, Harper,P.S., 1983



Showing articles 550 to 600 of 657 << Previous Next >>